Middle East and Africa Stroke Diagnostics Market, By Severity (Moderate, Severe, Mild), Type (Computed Tomography (CT Scan), Computed Tomography Angiography (CTA), Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA), Transcranial Doppler Ultrasound, Video Head Impulse Test (VHIT), Others), Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attacks (TIAS)), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare), Distribution Channel ( Direct Tender, Third Party Distributors, Others), Stage (Pre Operative, Peri Operative, Post Operative), Country (Saudi Arabia, South Africa, and Rest of the Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Middle East and Africa Stroke Diagnostics Market
The Middle East and Africa stroke diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.7% in the forecast period of 2021 to 2028 and is expected to reach USD 222.27 million by 2028. Rising disposable incomes and an increase in new product development are the major drivers which are expected to propel the demand of the market in the forecast period. However, an increase in restriction during a pandemic may restrain the market.
A stroke occurs when the supply of blood to the brain is decreased or blocked completely, which prevents the brain tissue from getting oxygen and nutrients. There are various types of diagnostics devices that are being used to detect stroke and its early symptoms, for instance, computed tomography (CT SCAN), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound and others.
The increasing incidence of stroke and cardiovascular and neurological disease has increased the demand for stroke diagnostics in developing countries. Also, the rise in healthcare expenditure is propelling market growth. On the other hand, the high cost of diagnosis may hinder market growth. The presence of market players and new product launches is providing an opportunity. However, the lack of skilled professionals may challenge the market.
The stroke diagnostics market report provides details of market share, new developments, the impact of domestic and localized market players, analysis of opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Middle East And Africa Stroke Diagnostics Market Scope And Market Size
The Middle East and Africa stroke diagnostics market is segmented on the basis of severity, type, application, end user, distribution channel, and stage.
- On the basis of severity, the Middle East and Africa stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market, with an increase in the increasing awareness regarding stroke and early diagnosis.
- On the basis of type, the Middle East and Africa stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), other. In 2021, the computed tomography (CT scan) segment is expected to dominate the market with the increasing government initiatives to provide a better diagnosis.
- On the basis of application, the Middle East and Africa stroke diagnostics market is segmented into an ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS). In 2021, ischemic stroke is expected to dominate the market with favorable government regulations regarding diagnostic devices.
- On the basis of end-users, the Middle East and Africa stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the market due to the increasing healthcare expenditure and advancement in hospital facilities.
- On the basis of distribution channel, the Middle East and Africa stroke diagnostics market is segmented into direct tender, third party distributor, and others. In 2021, direct tender is expected to dominate the market due to the direct link of the manufacturer to the customers.
- On the basis of stages, the Middle East and Africa stroke diagnostics market is segmented into pre-operative, peri-operative, and post-operative. In 2021, pre-operative is expected to dominate the market due to the increasing prevalence of heart disease.
Middle East and Africa Stroke Diagnostics Market Country Level Analysis
The Middle East and Africa stroke diagnostics market is analyzed, and market size information is provided on the basis of severity, type, application, end user, distribution channel, and stage.
The countries covered in the stroke diagnostics market report are South Africa, Saudi Arabia, and the rest of the Middle East and Africa.
The Middle East and Africa stroke diagnostics market is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of the increasing number of stroke diagnostics manufacturers and R&D activities. South Africa is expected to dominate the Middle East and Africa stroke diagnostics market due to an increase in the incidence of disease of cardiovascular diseases in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Rising New Product Development Are Boosting the Market Growth Of Stroke Diagnostics
The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the Stroke diagnostics technology, and changes in regulatory scenarios with their support for the Stroke diagnostics market. The data is available for the historic period 2011 to 2019.
Competitive Landscape and Stroke diagnostics Market Share Analysis
Stroke diagnostics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.
The major companies which are dealing in the Middle East and Africa stroke diagnostics market are Siemens, Koninklijke Philips N.V., General Electric Company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Analogic Corporation, Aspect Imaging Ltd, Carestream Health, ESAOTE SPA, Hologic, Inc., IMRIS, Deerfield Imaging Inc., MEDTRON AG, Neusoft Corporation, SAMSUNG, Shenzhen Anke High-Tech CO., Ltd., Shimadzu Corporation, SternMed GmbH, Stryker, among others.
Many product launches and agreements are also initiated by companies worldwide, which also accelerates the stroke diagnostics market.
For instance,
- In May 2021, Shimadzu Corporation announced its joint research agreement with Washington University School of Medicine in St. Louis to apply mass spectrometry technology toward the development of new products. It will enhance the company's R&D activities
- In November 2020, Stryker announced that it had acquired the Wright Medical Group N.V., a medical devices company focused on extremities and biologics across the globe. The acquisition done by the company has increased the product portfolio of the company leading to increased sales and demand for its products in the future
Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player are enhancing the company market in the stroke diagnostics market, which also provides the benefit for the organization to improve their offering for stroke diagnostics.
SKU-
